Logo image of MNKD

MANNKIND CORP (MNKD) Stock Fundamental Analysis

USA - NASDAQ:MNKD - US56400P7069 - Common Stock

5.07 USD
-0.18 (-3.43%)
Last: 11/13/2025, 8:00:01 PM
5.14 USD
+0.07 (+1.38%)
Pre-Market: 11/14/2025, 4:41:54 AM
Fundamental Rating

5

MNKD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. MNKD has an average financial health and profitability rating. MNKD is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

MNKD had positive earnings in the past year.
MNKD had a positive operating cash flow in the past year.
In the past 5 years MNKD reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MNKD reported negative operating cash flow in multiple years.
MNKD Yearly Net Income VS EBIT VS OCF VS FCFMNKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

MNKD's Return On Assets of 5.81% is amongst the best of the industry. MNKD outperforms 91.90% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.48%, MNKD belongs to the top of the industry, outperforming 97.18% of the companies in the same industry.
Industry RankSector Rank
ROA 5.81%
ROE N/A
ROIC 18.48%
ROA(3y)-8.37%
ROA(5y)-20.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNKD Yearly ROA, ROE, ROICMNKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

With an excellent Profit Margin value of 9.16%, MNKD belongs to the best of the industry, outperforming 91.71% of the companies in the same industry.
Looking at the Operating Margin, with a value of 27.48%, MNKD belongs to the top of the industry, outperforming 96.05% of the companies in the same industry.
MNKD has a Gross Margin of 78.49%. This is amongst the best in the industry. MNKD outperforms 84.37% of its industry peers.
MNKD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.48%
PM (TTM) 9.16%
GM 78.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.44%
GM growth 5Y5.99%
MNKD Yearly Profit, Operating, Gross MarginsMNKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

4

2. Health

2.1 Basic Checks

MNKD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MNKD has been increased compared to 1 year ago.
Compared to 5 years ago, MNKD has more shares outstanding
Compared to 1 year ago, MNKD has an improved debt to assets ratio.
MNKD Yearly Shares OutstandingMNKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
MNKD Yearly Total Debt VS Total AssetsMNKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

MNKD has an Altman-Z score of -5.45. This is a bad value and indicates that MNKD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MNKD (-5.45) is worse than 62.52% of its industry peers.
MNKD has a debt to FCF ratio of 8.39. This is a slightly negative value and a sign of low solvency as MNKD would need 8.39 years to pay back of all of its debts.
The Debt to FCF ratio of MNKD (8.39) is better than 91.15% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.39
Altman-Z -5.45
ROIC/WACC2.22
WACC8.33%
MNKD Yearly LT Debt VS Equity VS FCFMNKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

MNKD has a Current Ratio of 3.29. This indicates that MNKD is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 3.29, MNKD is not doing good in the industry: 61.21% of the companies in the same industry are doing better.
MNKD has a Quick Ratio of 3.04. This indicates that MNKD is financially healthy and has no problem in meeting its short term obligations.
MNKD has a Quick ratio of 3.04. This is in the lower half of the industry: MNKD underperforms 61.02% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.04
MNKD Yearly Current Assets VS Current LiabilitesMNKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 174.00% over the past year.
Looking at the last year, MNKD shows a quite strong growth in Revenue. The Revenue has grown by 17.44% in the last year.
The Revenue has been growing by 35.29% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)174%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%235%
Revenue 1Y (TTM)17.44%
Revenue growth 3Y55.86%
Revenue growth 5Y35.29%
Sales Q2Q%17.2%

3.2 Future

MNKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.96% yearly.
The Revenue is expected to grow by 13.27% on average over the next years. This is quite good.
EPS Next Y18.4%
EPS Next 2Y5.62%
EPS Next 3Y32.25%
EPS Next 5Y43.96%
Revenue Next Year14.19%
Revenue Next 2Y16.74%
Revenue Next 3Y15.12%
Revenue Next 5Y13.27%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MNKD Yearly Revenue VS EstimatesMNKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
MNKD Yearly EPS VS EstimatesMNKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.21, which means the current valuation is very expensive for MNKD.
Based on the Price/Earnings ratio, MNKD is valued cheaper than 91.34% of the companies in the same industry.
MNKD is valuated rather expensively when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 56.81, MNKD can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MNKD is valued cheaper than 89.45% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.57. MNKD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 36.21
Fwd PE 56.81
MNKD Price Earnings VS Forward Price EarningsMNKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

MNKD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNKD is cheaper than 94.35% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MNKD is valued cheaply inside the industry as 92.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 35.85
EV/EBITDA 15.75
MNKD Per share dataMNKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MNKD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MNKD's earnings are expected to grow with 32.25% in the coming years.
PEG (NY)1.97
PEG (5Y)N/A
EPS Next 2Y5.62%
EPS Next 3Y32.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNKD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MANNKIND CORP

NASDAQ:MNKD (11/13/2025, 8:00:01 PM)

Premarket: 5.14 +0.07 (+1.38%)

5.07

-0.18 (-3.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners55.89%
Inst Owner Change-0.37%
Ins Owners1.51%
Ins Owner Change2.38%
Market Cap1.56B
Revenue(TTM)313.79M
Net Income(TTM)28.75M
Analysts85.71
Price Target10.58 (108.68%)
Short Float %8.34%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)53.26%
Min EPS beat(2)-100%
Max EPS beat(2)206.52%
EPS beat(4)1
Avg EPS beat(4)19.34%
Min EPS beat(4)-100%
Max EPS beat(4)206.52%
EPS beat(8)2
Avg EPS beat(8)-31.68%
EPS beat(12)5
Avg EPS beat(12)-2.87%
EPS beat(16)6
Avg EPS beat(16)-4.99%
Revenue beat(2)1
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)0.33%
Revenue beat(4)3
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)0.9%
Revenue beat(8)6
Avg Revenue beat(8)1.65%
Revenue beat(12)8
Avg Revenue beat(12)2.45%
Revenue beat(16)11
Avg Revenue beat(16)3.58%
PT rev (1m)-1.86%
PT rev (3m)13.7%
EPS NQ rev (1m)-24.99%
EPS NQ rev (3m)-53.12%
EPS NY rev (1m)-12.16%
EPS NY rev (3m)-48.89%
Revenue NQ rev (1m)-3.95%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)-1.35%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 36.21
Fwd PE 56.81
P/S 4.96
P/FCF 35.85
P/OCF 31.84
P/B N/A
P/tB N/A
EV/EBITDA 15.75
EPS(TTM)0.14
EY2.76%
EPS(NY)0.09
Fwd EY1.76%
FCF(TTM)0.14
FCFY2.79%
OCF(TTM)0.16
OCFY3.14%
SpS1.02
BVpS-0.15
TBVpS-0.17
PEG (NY)1.97
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.81%
ROE N/A
ROCE 22.37%
ROIC 18.48%
ROICexc 48.2%
ROICexgc 50.4%
OM 27.48%
PM (TTM) 9.16%
GM 78.49%
FCFM 13.83%
ROA(3y)-8.37%
ROA(5y)-20.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.44%
GM growth 5Y5.99%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.39
Debt/EBITDA 3.59
Cap/Depr 64.99%
Cap/Sales 1.74%
Interest Coverage 9.12
Cash Conversion 51.63%
Profit Quality 150.89%
Current Ratio 3.29
Quick Ratio 3.04
Altman-Z -5.45
F-Score8
WACC8.33%
ROIC/WACC2.22
Cap/Depr(3y)397.13%
Cap/Depr(5y)337.1%
Cap/Sales(3y)10.78%
Cap/Sales(5y)10.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)174%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%235%
EPS Next Y18.4%
EPS Next 2Y5.62%
EPS Next 3Y32.25%
EPS Next 5Y43.96%
Revenue 1Y (TTM)17.44%
Revenue growth 3Y55.86%
Revenue growth 5Y35.29%
Sales Q2Q%17.2%
Revenue Next Year14.19%
Revenue Next 2Y16.74%
Revenue Next 3Y15.12%
Revenue Next 5Y13.27%
EBIT growth 1Y48.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y237.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y386.62%
OCF growth 3YN/A
OCF growth 5YN/A

MANNKIND CORP / MNKD FAQ

What is the fundamental rating for MNKD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MNKD.


What is the valuation status for MNKD stock?

ChartMill assigns a valuation rating of 5 / 10 to MANNKIND CORP (MNKD). This can be considered as Fairly Valued.


Can you provide the profitability details for MANNKIND CORP?

MANNKIND CORP (MNKD) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for MNKD stock?

The Earnings per Share (EPS) of MANNKIND CORP (MNKD) is expected to grow by 18.4% in the next year.